Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes.
about
Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD-A Systematic ReviewMeta-analysis of the influence of TM6SF2 E167K variant on Plasma Concentration of Aminotransferases across different Populations and Diverse Liver Phenotypes.MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C.E167K polymorphism of TM6SF2 gene affects cell cycle of hepatocellular carcinoma cell HEPA 1-6.The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B.Hepatitis B and concomitant hepatic steatosis.Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era.The effect of the TM6SF2 E167K variant on liver steatosis and fibrosis in patients with chronic hepatitis C: a meta-analysis.TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype.Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study.Significant positive association of endotoxemia with histological severity in 237 patients with non-alcoholic fatty liver disease.Hepatic steatosis in chronic hepatitis B: a study of metabolic and genetic factors.The Genetics of Clinical Liver Diseases: Insight into the E167K Variant
P2860
Q28070408-2815FACE-D13D-446E-9682-0D84146770DCQ36985932-2283F18C-621F-4906-A664-4CC493E2176EQ37264708-1D98D285-AA2B-4D19-A3EA-45226FFF84A9Q38707814-38E0BAE4-864B-40E7-98EE-E07C603D638FQ39008629-9237C9C6-4E62-4A80-AD4E-4DE89AD4C7D0Q39157327-2F71BC44-9722-4138-B27D-2D36091935DEQ40051943-DEEE338D-46BA-4779-9F93-03CC370141C3Q40071098-307A9046-4F53-4D13-BF79-76AB8CE6F0FFQ40482870-53247545-FBC8-4209-AFBF-9ACE11B9A038Q47949339-9FCC52C1-2DA7-4502-98CC-C8F12DD1F624Q48206905-0DB18C21-C2A8-4596-99D5-5DE1326C0013Q54213163-E47DC17B-14F7-4EF5-A718-EC5183325897Q57066897-E6FA61F5-24F9-43C6-9BA3-49DB630AFD41
P2860
Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Diverse impacts of the rs58542 ...... olic liver disease phenotypes.
@en
type
label
Diverse impacts of the rs58542 ...... olic liver disease phenotypes.
@en
prefLabel
Diverse impacts of the rs58542 ...... olic liver disease phenotypes.
@en
P2093
P2860
P50
P356
P1433
P1476
Diverse impacts of the rs58542 ...... olic liver disease phenotypes.
@en
P2093
Alessandra Mangia
Antony Rahme
Christopher Liddle
David R Booth
David van der Poorten
Duncan McLeod
Gregory J Dore
Henry Lik Yuen Chan
International Liver Disease Genetics Consortium
Jacob George
P2860
P356
10.1002/HEP.28475
P407
P577
2016-01-28T00:00:00Z